Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
Benjamín L. Sievers(University of Cambridge), Gene S. Tan(J. Craig Venter Institute), Mark M. Davis(Stanford Medicine), Prasanna Jagannathan(Palo Alto University), Kari C. Nadeau(Palo Alto University), Matthew B. Frieman(University of Maryland, Baltimore), Richard H. Scheuermann(Los Alamos National Laboratory), Bali Pulendran(Palo Alto University), Prabhu S. Arunachalam(Stanford University), Terri Gelbart(J. Craig Venter Institute), Yong Xue(J. Craig Venter Institute), Joseph C. González(Complejo Hospitalario Universitario de Santiago), Upinder Singh(University of Iowa), Saborni Chakraborty(Stanford University), Scott D. Boyd(Stanford University), Taia T. Wang(Chan Zuckerberg Initiative (United States)), Yarden Golan(Cornell University), Catherine A. Blish(Chan Zuckerberg Initiative (United States)), Arianna G. Cassidy(University of California, San Francisco), Sanjay Vashee(J. Craig Venter Institute), Stephanie L. Gaw(University of California, San Francisco), Mary Prahl(University of California, San Francisco)
Cited by 125
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
|Nature Medicine|1999|1.1k
Prevalence and Severity of Food Allergies Among US Adults
|JAMA Network Open|2019|1k
Animal models for COVID-19
|Nature|2020|877